Physician profile
Beau Gardner
NPI 1093798993
$8,507.34
in general payments reported to CMS, 2019-2025
34 companies · $1,776 in 2025
The $1,776 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $932 · 2020: $440 · 2021: $916 · 2022: $1,363 · 2023: $1,338 · 2024: $1,741 · 2025: $1,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,855.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,447.00 | 2019-2025 | Clareon, Hydrus Microstent, Unity |
| Glaukos Corporation | $881.44 | 2019-2025 | Idosetr, Idose, Iaccess Precision Blade |
| Sun Pharmaceutical Industries INC. | $713.24 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $384.38 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Tarsus Pharmaceuticals, INC. | $373.18 | 2024-2025 | Xdemvy |
| Abbvie INC. | $350.97 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $252.45 | 2021-2025 | Acthar |
| Allergan, INC. | $235.39 | 2020-2022 | |
| New World Medical,INC. | $207.24 | 2023-2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Kala Pharmaceuticals, INC. | $169.42 | 2019-2022 | |
| Sight Sciences, INC. | $163.40 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Novartis Pharmaceuticals Corporation | $145.09 | 2020-2023 | |
| Oyster Point Pharma, INC. | $132.21 | 2022-2025 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $115.20 | 2019 | |
| Hoffmann-La Roche Limited | $111.78 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $108.29 | 2019-2021 | |
| Harrow Eye, LLC | $98.54 | 2024-2025 | Iheezo |
| Johnson & Johnson Surgical Vision, INC. | $85.44 | 2022-2025 | Tecnis Simplicity, Catalys System |
| Ocular Therapeutix, INC. | $74.46 | 2019-2025 | Dextenza |
| Ivantis, INC | $66.31 | 2020 | |
| Amgen INC. | $59.41 | 2025 | Tepezza |
| Dompe US, INC. | $41.35 | 2021-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.18 | 2019-2021 | |
| Nova Eye, INC. | $33.23 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $33.07 | 2023 | Clarus |
| Shire North American Group INC | $32.97 | 2019 | |
| Iridex Corporation | $29.55 | 2019 | |
| Thea Pharma INC. | $20.98 | 2024 | Iyuzeh |
| Eyepoint US, INC. | $20.30 | 2019 | |
| Halozyme INC | $19.72 | 2023 | |
| Ironshore Pharmaceuticals INC. | $19.63 | 2020 | |
| Rxsight INC | $17.46 | 2022 | |
| Aerie Pharmaceuticals, INC. | $17.06 | 2019 | |
| Omeros Corporation | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beau Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.